Yasufumi Matsuda1,2, Haruka Sakai1, Shiho Masunaga1, Yumie Ebita1, Kana Oiwa2, Shin Lee2, Miyuki Ookura2, Toshiki Tasaki2, Naoko Hosono2, Yoshimasa Urasaki3, Takahiro Yamauchi1,2 (1.Blood Transfusion, Univ. of Fukui, Fukui, Japan, 2.Hematol. and Oncol., Univ. of Fukui, Fukui, Japan, 3.Health Administration center, Univ. of Fukui, Fukui, Japan)
Session information
Poster Session
Fri. Oct, 12
Poster Session 1-23 Stem cell collection/Others
Fri. Oct 12, 2018 5:30 PM - 6:10 PM Poster2 (Osaka International Convention Center, 5F Main Foyer)
Chair: Yoshihiro Fujimori (Dinvision of Hematology, Department of International Medicine Hyogo College of Medicine)
Naoto Imoto, Rie Ito, Koji Umemura, Daisuke Koyama, Shingo Kurahashi, Isamu Sugiura (Hematol Toyohashi municipal hosp, Toyohashi, Japan)
Yukihiro Kanai1, Akihiko Yokohama3, Tetsuhiro Kasamatsu1, Maaya Awata1, Keisuke Murata1, Takayuki Saitoh1, Hiroshi Handa2, Hirono Iriuchishima2, Tomomi Sekigami3, Hirokazu Murakami1 (1.Gunma University Graduate School of Health Sciences, Gunma, Japan, 2.Department of Medicine and Clinical Science, Gunma University, Gunma, Japan, 3.Blood Transfusion Service, Gunma University Hospital, Gunma, Japan)
Yuma Tada1, Shigeo Fuji1, Ryo Nakata1, Shuhei Kida1, Kazuhito Tsutsumi1, Keiichi Nakata1, Midori Koike1, Hiroaki Masaie1, Hitoshi Yoshida1, Sachika Mitani2, Yuhei Iwata2, Yuki Morimoto2, Shoichi Indou2, Hidema Tanaka3, Akemi Higeno3, Atsushi Itoda3, Jun Ishikawa1 (1.Hematlol., Osaka International Cancer Institute, Osaka, Japan, 2.Anesthesiol., Osaka International Cancer Institute, Osaka, Japan, 3.Lab Med., Osaka International Cancer Institute, Osaka, Japan)
Ai Matsuura, Yuuichi Yamada, Satoru Mukai, Masaru Shibano (Sakai City Medical Center, Osaka, Japan)
Yusuke Yamaga1, Yasuhiro Suzuki1, Masanori Iwai1, Koichi Miyamura2 (1.Department of hematology , Gifu Prefectural Tajimi Hospital, Japan, 2.Department of hematology, Japanese Red Cross Nagoya Daiichi Hospital, Japan)
Masataka Takeshita1,2, Risen Hirai1, Akira Tanimura1, Daisuke Kudo1, Akiyoshi Miwa1,2 (1.Division of Hematology, Tokyo-Kita Medical Center, 2.International Myeloma Center for Advanced Research and Development)